1. Home
  2. ALLO vs MPX Comparison

ALLO vs MPX Comparison

Compare ALLO & MPX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ALLO
  • MPX
  • Stock Information
  • Founded
  • ALLO 2017
  • MPX 1965
  • Country
  • ALLO United States
  • MPX United States
  • Employees
  • ALLO N/A
  • MPX N/A
  • Industry
  • ALLO Biotechnology: Biological Products (No Diagnostic Substances)
  • MPX Marine Transportation
  • Sector
  • ALLO Health Care
  • MPX Industrials
  • Exchange
  • ALLO Nasdaq
  • MPX Nasdaq
  • Market Cap
  • ALLO 277.8M
  • MPX 297.8M
  • IPO Year
  • ALLO 2018
  • MPX N/A
  • Fundamental
  • Price
  • ALLO $1.21
  • MPX $9.10
  • Analyst Decision
  • ALLO Strong Buy
  • MPX Hold
  • Analyst Count
  • ALLO 9
  • MPX 1
  • Target Price
  • ALLO $8.44
  • MPX $8.00
  • AVG Volume (30 Days)
  • ALLO 2.5M
  • MPX 26.2K
  • Earning Date
  • ALLO 08-06-2025
  • MPX 07-24-2025
  • Dividend Yield
  • ALLO N/A
  • MPX 6.15%
  • EPS Growth
  • ALLO N/A
  • MPX N/A
  • EPS
  • ALLO N/A
  • MPX 0.43
  • Revenue
  • ALLO N/A
  • MPX $226,217,000.00
  • Revenue This Year
  • ALLO N/A
  • MPX $3.97
  • Revenue Next Year
  • ALLO $199.63
  • MPX $13.02
  • P/E Ratio
  • ALLO N/A
  • MPX $21.10
  • Revenue Growth
  • ALLO N/A
  • MPX N/A
  • 52 Week Low
  • ALLO $0.86
  • MPX $7.49
  • 52 Week High
  • ALLO $3.78
  • MPX $10.89
  • Technical
  • Relative Strength Index (RSI)
  • ALLO 43.73
  • MPX 63.17
  • Support Level
  • ALLO $1.11
  • MPX $8.46
  • Resistance Level
  • ALLO $1.29
  • MPX $8.97
  • Average True Range (ATR)
  • ALLO 0.09
  • MPX 0.35
  • MACD
  • ALLO -0.01
  • MPX 0.09
  • Stochastic Oscillator
  • ALLO 25.81
  • MPX 100.00

About ALLO Allogene Therapeutics Inc.

Allogene Therapeutics Inc is a clinical-stage biotech firm specializing in immuno-oncology, focusing on the development of genetically engineered allogeneic T-cell products for cancer and autoimmune diseases. Their pipeline includes off-the-shelf T-cell candidates designed to target cancer cells or autoreactive cells in autoimmune disorders. Notably, their allogeneic approach, derived from healthy donors, allows for broader patient eligibility and scalability. With a vision to redefine CAR T therapy, the company concentrates on core programs targeting lymphoma, leukemia, autoimmune diseases, and solid tumors. Revenue, generated from collaborations and licensing agreements, supports their research and development efforts.

About MPX Marine Products Corporation

Marine Products Corp is a manufacturer of fiberglass motorized boats distributed and marketed through its independent dealer network. The company's only operating segment is Powerboat Manufacturing Business. It operates in the powerboat manufacturing business segment in Nashville, Valdosta, and Georgia. Its product offerings include Chaparral sterndrive, outboard pleasure boats, and Robalo outboard sport fishing boats. The company offers its products to the family recreational markets through its Chaparral brand and to the sportfishing market through its Robalo brand.

Share on Social Networks: